Renal Cancers Terminated Phase 2 Trials for Everolimus (DB01590)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00831480Everolimus (RAD001) For Advanced Renal Cell Carcinoma (RCC) Before Kidney RemovalPrevention
NCT01888042Assessing Everolimus in Fist Line Treatment on Patients With Metastatic Kidney CancerTreatment
NCT02504892Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal CancerTreatment